Kairos Pharma, LTD.

KAPA · NYSE · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 1 employees
50
SEC Filings
$1.67
Close 2026-09-03
1
Employees

Business Summary

Kairos Pharma, LTD. is a clinical-stage biopharmaceutical company developing therapeutics for cancer patients targeting immune suppression and drug resistance. Its seven-drug portfolio includes antibodies and small molecules (KROS 101, 102, 201, 301, 401) and biologics (ENV 105, ENV 205) for prostate cancer, lung cancer, breast cancer, and glioblastoma. Technologies are licensed from Cedars-Sinai Medical Center. The company operates through its subsidiary Enviro Therapeutics, Inc. and conducts clinical trials at third-party facilities.

Latest Stock Quote

KAPA 2026-09-03 $1.67 O:$1.55 H:$1.6899 L:$1.55 Vol:0.0M VWAP:$1.6251
origin leaf: null

Next Earnings

expected 2026-12-14

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001493152-26-014159EDGAR109K words
2025-04-152024-12-310001641172-25-004920EDGAR97K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-122026-06-300001493152-26-037355EDGAR20K words
2025-11-142025-09-300001493152-25-023276EDGAR19K words
2025-08-122025-06-300001641172-25-023167EDGAR20K words
2025-05-142025-03-310001641172-25-010089EDGAR18K words
2024-11-142024-09-300001493152-24-045671EDGAR23K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-09-140001493152-26-042569EDGAR0K words
2026-08-210001493152-26-039695EDGAR1K words
2026-07-220001493152-26-034185EDGAR1K words
2026-07-150001493152-26-033289EDGAR1K words
2026-03-020001493152-26-008435EDGAR1K words
2026-02-260001493152-26-008116EDGAR1K words
2025-10-150001493152-25-018145EDGAR1K words
2025-10-070001493152-25-017208EDGAR1K words
2025-09-180001493152-25-013975EDGAR1K words
2025-09-110001493152-25-013040EDGAR1K words

50 total filings indexed. 33 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

prostate-cancer-therapeutics non-small-cell-lung-cancer-therapeutics glioblastoma-therapeutics breast-cancer-therapeutics cancer-immunotherapy recist-1.1 pcwg3

Company Identity

CIK0001962011
TickerKAPA
ExchangeNYSE
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.kairospharma.com
Listed2024-09-16

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: d2b3e25e40aa4367e0c7cbaaac4b7b6cb71eeaaf9e4b752e739e9e0edfad2174
parent: dcb66ae835c4b5b068bfb969e234e929843c74c155273a3a473378efc5d22a9d
content hash: b30f40ce6a07aa06fe5495842f4f4262069f54f6325ffe43f1f8f77c0912be31
signed: 2026-09-28T19:01:52.122Z
sources: 7 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up KAPA using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on KAPA, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/KAPA (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.